Pharma Exclusives Pressreleases
Ipsen, Université de Montréal and IRICoR expand long-term partnership to accelerate early-stage oncology innovations
Monday, December 22, 2025Ipsen Universit de Montral and IRICoR of the Institute for Research in Immunology and Cancer IRIC at the Universit de Montral announced today a new research collaboration and option agreement
Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation
Saturday, December 20, 2025Hansa Biopharma AB today announced the submission of a Biologics License Application BLA to the US Food and Drug Administration FDA for imlifidase The Company is requesting priority review of the BLA
Hansa provides update on Pivotal Phase 3 trial in anti-glomerular basement membrane (anti-GBM) disease
Wednesday, December 17, 2025Hansa Biopharma AB Hansa Nasdaq Stockholm HNSA today announced that GOODIDES a global pivotal Phase trial in antiglomerular basement membrane antiGBM disease did not meet its primary endpoint
Novo Nordisk has completed its acquisition of Akero Therapeutics
Wednesday, December 10, 2025Novo Nordisk and Akero Therapeutics Inc today announced that Novo Nordisks acquisition of Akero announced on October has been completed
European Commission approves Roche’s Gazyva/Gazyvaro for adults with active lupus nephritis
Tuesday, December 09, 2025Roche announced today that the European Commission has approved GazyvaGazyvaro obinutuzumab in combination with mycophenolate mofetil MMF for the treatment of adult patients
ProBioGen and Spica Therapeutics Announce Collaboration on GlymaxX-Enhanced CLD for Spica’s Clinical Development Candidate ST101
Tuesday, December 09, 2025ProBioGen and Spica Therapeutics Spica a pioneering biotechnology company advancing pathogenic macrophage subsettargeted immunotherapies today announced a new collaboration Under the agreement ProBioGen
Roche receives FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough (pertussis)
Tuesday, December 02, 2025Roche announced today that its first pointofcare test for the diagnosis of whooping cough pertussis and other Bordetella infections has been granted US Food and Drug Administration FDA k
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
Friday, November 07, 2025Today it was announced that Novo Nordisk has agreed with the US Administration to lower drug prices beginning in and expand patient access and affordability for semaglutide medicines including Wegovy
Touchlight Expands mbDNA™ Portfolio with New Circular DNA Architectures for Advanced Therapies
Thursday, November 06, 2025Touchlight a leader in cellfree DNA technology today announced the expansion of its groundbreaking mbDNA platform with the introduction of three new circular DNA architectures sscDNA hsscDNA and dscDNA
ABER Instruments and Sartorius Stedim Biotech Unveil BioPAT® Viamass Single-Use Biomass Sensors for Ambr® 250 High Throughput Bioreactors
Tuesday, November 04, 2025Aber Instruments and Sartorius Stedim Biotech today announced the introduction of the BioPATViamass singleuse biomass sensor now fully integrated into Ambr High Throughput singleuse bioreactor vessels
